EFhd2 and tau granules have been observed in fractions obtained from Alzheimer disease (AD) brains, suggesting a novel amyloid protein may form nucleation centers to induce the formation of tau aggregates (Ferrer-Acosta et al., 2013 ▸). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.